Is Galleri the future of cancer treatment? It's not that simple. The new research from the company, while promising, isn't some cure-all.

Add Yahoo as a preferred source to see more of our stories on Google. Grail's Galleri test screens for more than 50 different types of cancer from a single blood draw. (Getty Images) (Getty Images) If ...

Guardant Health Inc. (NASDAQ:GH) is one of the most promising stocks under $100 to buy. On March 16, Guardant Health announced the launch of its Shield multi-cancer detection/MCD test in several Asian ...

Forbes contributors publish independent expert analyses and insights. Greg Licholai writes and teaches about innovation in healthcare. It should be noted that the Galleri test not currently ...

A blood test for more than 50 types of cancer could significantly boost early detection and speed up diagnosis, according to a new study. Made by U.S. pharmaceutical company Grail, the Galleri test ...

For doctors and patients, the Holy Grail of medicine would be a simple blood or saliva test to detect all types of cancer before symptoms or sickness appears. Doctors could screen and treat patients ...

A Bay Area biotech company says its groundbreaking blood test can detect more than 50 cancers. Early detection can improve cancer outcomes and can save lives. Cancer is the second leading cause of ...

Some claim the new multi-cancer detection tests will “revolutionize” cancer screening. Others fear the “worried well” will succumb to slick marketing and subpar tests and overwhelm both primary care ...

Medicare will now cover tests that screen for multiple types of cancer at once, under a new bipartisan law backed by Georgia ...

This is key to preventing cervical cancer or catching it early. Cervical cancer can cause fertility issues, pain, kidney ...